NASDAQ:SENS Senseonics Holdings, Inc. Common Stock 11/7/2024 Earnings Report $5.54 +0.15 (+2.69%) As of 10:43 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Senseonics Holdings, Inc. Common Stock EPS ResultsActual EPS-$0.80Consensus EPS -$0.60Beat/MissMissed by -$0.20One Year Ago EPSN/ASenseonics Holdings, Inc. Common Stock Revenue ResultsActual Revenue$4.26 millionExpected Revenue$4.02 millionBeat/MissBeat by +$240.00 thousandYoY Revenue GrowthN/ASenseonics Holdings, Inc. Common Stock Announcement DetailsQuarterDate11/7/2024TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Senseonics Holdings, Inc. Common Stock Earnings HeadlinesSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Receives Consensus Recommendation of "Moderate Buy" from AnalystsJune 23 at 3:37 AM | americanbankingnews.comReal-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop SystemsJune 6, 2026 | globenewswire.comSpaceX Opens Up 11% — Here’s What You Need to KnowSpaceX - ticker SPCX - just completed the biggest IPO in American history, raising $75 billion at a $1.8 trillion valuation. Goldman Sachs projects $474 billion in revenue by 2030, while Morgan Stanley goes further - $3.4 trillion by 2040. But NYU's Aswath Damodaran, Wall Street's 'Dean of Valuation,' called those projections 'a hallucination.' While every camera pointed at the rockets, Musk quietly placed a major bet on what he calls 'the world's biggest product' - something he believes could generate $30 trillion in revenue. Sixty of America's largest companies are making the same move, and the signal appeared in a quiet Friday SEC filing almost nobody noticed.June 26 at 1:00 AM | Porter & Company (Ad)Senseonics Holdings, Inc. (SENS) Shareholder/Analyst Call TranscriptJune 6, 2026 | seekingalpha.comSenseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026June 1, 2026 | globenewswire.comSenseonics Holdings, Inc. (NASDAQ:SENS) Q1 2026 Earnings Call TranscriptMay 10, 2026 | insidermonkey.comSee More Senseonics Holdings, Inc. Common Stock Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Senseonics Holdings, Inc. Common Stock? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Senseonics Holdings, Inc. Common Stock and other key companies, straight to your email. Email Address About Senseonics Holdings, Inc. Common StockSenseonics Holdings, Inc. develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter. Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal. The company has pursued regulatory approvals and commercial rollouts in multiple geographies, including the United States and Europe, and has worked with distributors and clinical partners to make its system available to patients and diabetes care teams. Its offerings are intended to integrate with diabetes management workflows by providing real-time glucose data, trends and alerts to patients and clinicians. In addition to commercializing its implanted CGM technology, Senseonics continues to focus on product development, clinical evidence generation and expanding access through partnerships with healthcare providers and distributors. As a publicly traded company, Senseonics reports on its progress through regulatory filings and corporate disclosures; prospective investors and patients should review the company’s official materials for the latest information on regulatory status, availability and leadership.View Senseonics Holdings, Inc. Common Stock ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles BlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings AloneMicron’s HBM Surge Could Redefine the AI Growth StoryCarnival's Second Quarter: Is the Stock Still Complicated?This Single Factor Is Holding Back Carvana’s Disruptive EdgePaychex Stock Looks Beaten Down, But Not BrokenWhy KB Home Could Reward Patient Investors LaterWashington’s Quantum Push Puts IBM and IonQ on the Throne Upcoming Earnings NIKE (6/30/2026)PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Fastenal (7/13/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026)Wells Fargo & Company (7/14/2026)Citigroup (7/14/2026)ASML (7/15/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
